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1. introduction 
Lactation is characterized by a number of physiol- 
ogical changes including increased cardiac output [ 11, 
hypertrophy of liver [ 11, heart [ 11, intestine [2,3] 
and mammary gland [ 11, and an increase in dietary 
intake [2] (for details see table 1). In addition, there 
are profound alterations to the metabolism of the 
tissues of the lactating rat. The net result of these 
changes is that a high proportion of the substrates 
available in the circulation (glucose, triacylglycerols, 
non-esterified fatty acids and ketone bodies) are 
‘directed’ [4] to the gland for the production of milk. 
The aim of this contribution is to describe some of 
the metabolic changes that are known to occur during 
lactation in the rat and to speculate on the ‘signals’ 
(hormones or substrates) which may be involved. 
Lactation in other species will not be dealt with 
except where the data are pertinent to the situation 
in the rat. This contribution is not intended to be’a 
comprehensive review of the area or the literature and 
merely contains a selection of topics and questions 
which interest the writer. 
Information on the integration of tissue metabo- 
lism in the lactating rat is not only of fundamental 
interest, but is also relevant to the study of dietary- 
induced obesity, because despite a large increase in 
dietary intake (table 1) the lactating rat does not 
Table 1 
The effects of lactation on dietary intake, cardiac output, organ weights and 
organ blood flow in rats 
Measurement Lactating Non-lactating 
Day 12 
Day 1 Day 12 
Body weight (g) 252 315 285 
Dietary intake (g/24 h) 18 50 16 
Cardiac output (ml/min) 91 143 89 
Mammary gland 
Wet weight (g) 13.2 24.2 5.7 
Blood flow (ml . 100 g-l. min”) 33 62 12 
Liver 
Wet weight(g) 12.8 16.3 11.7 
Blood flow (ml. 100 g-‘. min”) 38 74 50 
Small intestine 
Wet weight (g) 12.2 21.5 10.7 
Blood flow (ml. 100 g-l. min”) 66 94 80 
Non-lactating rats refers to rats which had pups removed at birth. Data taken 
from [ 1 ] except dietary intake [ 21 
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become obese, and the mass of white adipose tissue 
may rictually decrease [S], although other workers 
suggest hat the weight of the parametrial fat body 
does not change [6]. 
2. Alterations in tissue metabolism during lactation Lactating rats 
In this section I intend to discuss briefly the over- 
all changes in metabolism which occur in certain key 
tissues of the lactating rat (for a summary see table 2). 
The major emphasis will be on carbohydrate and lipid 
metabolism. 
(IO-18 days) Glucose 28.2 
Lactate 6.3 
Pyruvate 0.6 
Total C, units 63.3 
Male rats Glucose turnover 
(330 g) (whole body) 33.9 
The values for substrate utilization by the gland refer to fed 
rats and werecalculated from arteriovenous difference mea- 
surements across the gland [45] and blood flow rates and 
gland weights [I]. Whole body glucose turnover for non- 
lactating rats is from [93] 
2.1. Lactating mammary gland 
The key to an understanding of the alterations in 
whole body metabolism during lactation are the sub- 
strate requirements of the gland for the production 
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Table 2 
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Carbohydrate requirements of the mammary gland of the 
lactating rat 
Substrate Flux rate 
(mmol/24 h) 
Tissue 
Mammary gland 
Liver 
White adipose 
tissue 
Brown adipose 
tissue Glucose utilization 
Lipogenesis 
Fatty acid oxidation 
Intestine Glucose utilization 
Lipogenesis 
Fatty acid esterification 
Amino acid metabolism 
? Indicates where information is not available 
Table 3 
Summary of metabolic changes during lactation in the rat 
Process 
Glucose utilization 
Lactose synthesis 
Lipogenesis 
Fatty acid esterification 
Triacylglycerol uptake 
Amino acid utilization 
Protein synthesis 
Glucose utilization (glycolysis) 
Lipogenesis 
Fatty acid esterification 
Ketogenesis 
Triacylglycerol secretion 
Amino acid metabolism 
Protein synthesis 
Change 
Increased 
Increased 
Increased 
Increased 
Increased 
Increased 
Increased 
Increased 
Increased 
Increased 
Decreased 
Decreased 
? 
? 
Glucose utilization 
Lipogenesis 
Triacylglycerol uptake 
Lipolysis 
Decreased 
Decreased 
Decreased 
Increased 
Decreased 
Decreased 
? 
? 
? 
? 
? 
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of the main components of milk: lactose, casein and tissue has an important role in heat production in 
lipid. On the normal aboratory diet (high in carbohy- non-shivering thermogenesis, but recent experiments 
drate and low in fat) all the lactose and casein, and suggest that this tissue may be important in ‘burning 
about 50% of the lipid are synthesized within the off excess energy, i.e., dietary-induced thermogenesis 
gland. It can be estimated [7] that at peak lactation [ 15,161. In the non-lactating rat there is a lo-fold 
the glucose uptake by the gland is about 30 mmol or increase in lipogenesis n interscapular brown adipose 
5.4 g/24 h of which about 7.0 mmo1/24 h is used for tissue after an intragastric load of glucose [171, but 
lactose synthesis [8] and the rest for lipogenesis this response does not occur in short-term (2 h) 
(table 3). Less important potential substrates for lipo- insulin deficiency [ 171. If the rate of lipogenesis can 
genesis in the gland include lactate and pyruvate be directly related to that of fat oxidation in this tis- 
(table 3). It is not widely appreciated that mammary sue then these findings provide further evidence for 
gland is the most active site of lipogenesis n vivo its role in dietary-induced thermogenesis. During 
during lactation; the rate of lipogenesis on a g tissue lactation the weight of the interscapular b own adi- 
basis being 5-fold higher than that of liver (table 7; pose tissue is not increased espite the hyperphagia 
[9]). The remainder of the milk lipid is derived from and the rate of lipogenesis n the tissue no longer 
triacylglycerols and non-esterified fatty acids taken increases in response to an intragastric load of glucose 
up from the blood [lo]. This large requirement of the [ 171. These changes in the metabolism of the tissue 
gland for glucose and triacylglycerols implies that the can be interpreted as aiding in the conservation of
rate of production or entry of these substrates i lipogenic substrates (mainly glucose) because it clearly 
increased and/or their rate of utilization by other tis- would not make physiological sense to ‘burn off 
sues is decreased. Part of the increased requirement excess energy in a situation in which the animal’s 
can be met by the higher dietary intake, but part requirements for substrates for the mammary gland 
must be met by changes in the metabolism of other are greatly increased. It would be of interest o exam- 
tissues. In addition, the gland must be able to respond ine whether blood flow to brown adipose tissue is 
rapidly to changes in the availability of these sub- decreased in lactation because this would also aid in 
strates in the circulation. substrate conservation. 
2.2. White adipose tissue 2.4. Liver 
In the non-lactating rat white adipose tissue is an 
important site of lipogenesis and therefore of glucose 
utilization. In addition, dietary fat, present in the 
circulation as chylomicrons, is taken up by adipose 
tissue for storage after hydrolysis to non-esterified 
fatty acids by lipoprotein lipase (EC 3.1 .1.34) and 
subsequent re-esterification within the tissue. During 
lactation the rate of lipogenesis n white adipose tis- 
sue in vivo [9] and in vitro [5,1 l] is considerably 
decreased as are the activities of certain key lipogenic 
enzymes [11,12]. Similarly, the activity of lipopro- 
tein lipase decreases rapidly at parturition and 
remains low throughout lactation [6,13]. In contrast, 
there is evidence in vitro for increased lipolysis in 
adipose tissue from lactating rats [ 141. The net result 
of these changes i that, in lactation, less glucose and 
triacylglycerol is removed by adipose tissue and more 
non-esterified fatty acids and glycerol are released to 
the blood stream. 
2.3. Brown adipose tissue 
It has long been appreciated that brown adipose 
The liver increases by about 40% in weight during 
lactation and this hypertrophy is accompanied by 
changes in the activity of enzymes concerned in the 
metabolism of carbohydrate and lipid. The activity 
of glucokinase (EC 2.7.1.2) increases at peak lacta- 
tion whereas the activities of key enzymes concerned 
in gluconeogenesis e ther remain constant (glucose 6- 
phosphatase , EC 3.1.3.9) or decrease (phosphoenol- 
pyruvate carboxykinase, EC 4.1 .1.32; pyruvate car- 
boxylase, EC 6.4.1.1) and this has led to the sugges- 
tion that glycolysis may be increased in the liver of 
the lactating rat [ 181. Evidence in support of this 
suggestion is the finding that hepatocytes from fed 
rats at peak lactation have a higher ate of glycolytic 
flux and a lower output of glucose compared to 
hepatocytes from virgin or pregnant rats [ 191. One 
important role of hepatic glycolysis is to supply car- 
bon for fatty acid synthesis. Two of the enzymes 
concerned in lipogenesis, namely ATP-citrate lyase 
(EC 4.1.3.8) and acetyl-CoA carboxylase (EC 6.4.1.2) 
are increased in activity in liver at peak lactation [ 181 
and in vitro measurements of lipogenesis with 3Hz0 
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have shown a 2-fold higher rate in hepatocytes from 
rats at peak lactation compared to that in liver cells 
from virgin rats [20]. Alterations to lipid metabolism 
in livers of lactating rats are not confined to the syn- 
thesis de novo of fatty acids. A higher proportion of 
long-chain fatty acid (oleate) taken up by isolated 
hepatocytes from fed lactating rats (lo-14 days) is 
converted to esterified products (mainly triacylgly- 
cerols) and less to ketone bodies than in hepatocytes 
from virgin rats [ 191. The net result of these changes 
in hepatic metabolism would be expected to be 
increased secretion of triacylglycerols, formed either 
by synthesis de novo of fatty acids (glycogen or glu- 
cose as substrate) or by esterification of long-chain 
fatty acids originating from adipose tissue (see section 
2.2). Recent measurements in vivo, however, have not 
confirmed this prediction in that the secretion rate of 
triacylglycerols (expressed on a 100 g/body wt basis) 
is decreased in early lactation and at peak lactation is 
similar to that for virgin rats ([21]; see section 4.2). 
2.5. Small intestine 
The small intestine of the rat increases in weight 
and length during lactation (table 1; [2,3]). There is 
hyperplasia of the mucosal epithelium and an increase 
in total absorptive capacity of the gut. However, the 
absorptive capacity per unit area of intestine for both 
monosaccharides and amino acids actually decreases 
[3] which suggests that the enterocytes may be 
less efficient or more immature. There has been much 
speculation on the mechanism for the intestinal 
hyperplasia during lactation. It has been attributed 
to: (i) ‘work hypertrophy’, i.e., induced by the 
increased food intake; or (ii) hormonal induction. 
Experiments in which exogenous luminal nutrition, 
or bile and pancreatic secretions, were excluded from 
the jejunum did not diminish the hyperplasia [22] 
suggesting the influence of some systemic factor. 
Hormones that might be responsible for the hyper- 
plasia include the obvious candidate, prolactin, and 
thyroxine and enteroglucagon. Prolactin administra- 
tion does not cause mucosal hyperplasia in virgin 
mice [23] nor does hyperprolactinaemia induced by 
perphenazine in rats [22]. However, treatment of 
rats with bromocryptine, which inhibits prolactin 
secretion, decreases the jejunal wet weight only in 
lactating rats [24]. One criticism of this study is that 
the possibility of changes in food intake was not 
considered. Hyperthyroidism in non-lactating rats 
results in a 30-400/o increase in intestinal weight [25] 
K96 
and there is evidence for raised concentrations of 
thyroid hormones during lactation [26]. 
In marked contrast, there have been comparatively 
few studies on the metabolic properties of the 
mucosal epithelium of lactating rats. The activities of 
glucose 6-phosphate dehydrogenase (EC 1 .l .I .49) 
and isocitrate dehydrogenase (EC 1 .l .I .42) increase 
in the mucosal epithelium, whereas those of lactate 
dehydrogenase (EC 1 .l .1.27), succinate-tetrazolium 
reductase (EC 1.3.9.9) and sucrase (EC 3.2.1.26) do 
not change significantly [27]. Dipeptidases which are 
important for the final stages of protein digestion, 
are increased considerably in activity in the small 
intestine during lactation [28]. 
3. Regulation of glucose metabolism and lipogenesis 
in the lactating mammary gland 
Glucose is the precursor for the synthesis of lac- 
tose and for a large proportion of milk fat, so that 
when its availability decreases (e.g., in starvation or 
on a low-carbohydrate diet) the gland’s requirement 
for this substrate must be decreased otherwise hypo- 
glycaemia might result because of the depletion of 
the animal’s carbohydrate reserves. Any discussion of 
the control of glucose utilization by the gland also 
involves consideration of the regulation of lipogene- 
sis, because only about 10% of the glucose utilized is 
completely oxidized in this tissue [29]. Thus in this 
section the overall pathway of glucose metabolism in 
the lactating gland is considered to be its conversion 
to lipid or to lactose. 
3.1. Potential regulatory enzymes of glucose 
metabolism 
One method of identifying regulatory enzymes is 
to compare the activities of the enzymes of the path- 
way with that of the flux rate of the substrate (i.e., 
glucose) of the pathway. On this basis the reactions 
catalysed by the following enzymes may be consid- 
ered potential regulatory sites in mammary gland: 
hexokinase, phosphofructokinase, pyruvate dehy- 
drogenase and acetyl-CoA carboxylase (table 4; [30]) 
and these enzymes have all been implicated as regula- 
tory enzymes in other tissues [3 11. Glucose metabo- 
lism requires hexokinase as the initiating enzyme, and 
this is present in the gland predominantly as the type 
I and II isoenzymes (Km for glucose 0.010-0.10 mM 
[32]; the intracellular glucose is thought to be 0.29 
Volume 117, Supplement FEBS LETTERS 25 August 1980 
Table 4 
Relative activities of the enzymes of glucose metabolism 
in the lactating mammary gland of the rat 
Pathways and enzymes Relative 
activity 
Glucose utilization 1 
Glucose activation 
Hexokinase 3.4 
Embden-Meyerhof pathway 
Phosphoglucose isomerase 
Phosphofructokinase 
Aldolase 
Glyceraldehyde 3-phosphate 
dehydrogenase 
Pyruvate kinase 
Lactate dehydrogenase 
162 
1.4-5.4 
11.2 
38 
32 
44 
Pentose phosphate pathway 
Glucose 6-phosphate 
dehydrogenase 
Gluconate 6-phosphate 
dehydrogenase 
Fatty acid synthesis 
62 
14 
Pyruvate dehydrogenase 1.5 
AcetylCoA carboxylase 0.44 
Fatty acid synthetase 13 
The rate of glucose utilization (1.6 pmol . min-‘. g wet wt-‘) 
in isolated acini [45] has been set at unity and the enzyme 
activities related to this. The activities are from [30] and 
have been corrected to 37°C 
mM [33]. The activity of phosphofructokinase is 
important in determining the glycolytic flux and the 
mammary gland enzyme like that from muscle, 
recently has been shown to be inhibited by citrate 
[34]. Pyruvate dehydrogenase determines the propor- 
tion of glucose carbon that is converted into lactate 
or lipid (acetyl-CoA) [35,36] and alterations in the 
activity of this enzyme play a key role in the regula- 
tion of glucose metabolism in the gland. Utilization 
of acetyl-CoA generated by cleavage of citrate in the 
cytosol is controlled by acetyl-CoA carboxylase, 
which is activated by citrate and Mg’+, and inhibited 
by certain fatty acids or their acyl-CoA esters in 
mammary gland [37,38]. One role of the pentose 
phosphate pathway is to supply NADPH for fatty 
acid synthesis and this pathway is present in high 
activity in the lactating gland. It is controlled by the 
availability of NADP’ and NADPH in the cytosol 
[39]; NADPH being a potent inhibitor of glucose 
6-phosphate dehydrogenase [40]. Thus a decrease in 
the rate of NADPH utilization for lipogenesis will 
result in inhibition of the pentose phosphate pathway 
activity. Flux through the glycolytic and pentose 
phosphate pathways is closely ‘coupled’ in mammary 
gland and other lipogenic tissues, but the mechanism 
which brings this about is not clear [29,30,41]. The 
primary rate-limiting step in lactose synthesis appears 
to be galactosyltransferase (EC 2.4.1.22) [42]. 
For a comprehensive review of the enzymes con- 
cerned in glucose metabolism in the lactating mam- 
mary gland see [30,32]. 
3.2. Effects of starvation 
In starvation the lactating rat is faced with two 
choices, either to continue to produce milk at a nor- 
mal rate with the consequent danger of complete 
depletion of its carbohydrate and fat reserves or alter- 
natively to decrease lactation and possibly lose the 
young. It appears that survival of the mother rather 
than the pups is more important and given the rat’s 
high fertility this is a sensible choice. For the bio- 
chemist the question is how is the inhibition of lacta- 
tion achieved? 
Starvation of lactating rats with their pups for 24 h 
results in a dramatic decrease in the glucose uptake 
by the mammary gland (as measured by arteriovenous 
differences) without any significant change in the 
arterial glucose concentration (table 5). This change 
in glucose utilization is accompanied by output of 
lactate and pyruvate by the gland, whereas in the fed 
state these substrates are taken up (table 5). Mam- 
mary gland blood flow may decrease on starvation so 
that the decrease in the rate of removal of glucose by 
the gland is likely to be even greater than that indica- 
ted by the arteriovenous differences. The lower rate 
of removal of glucose is accompanied by the expected 
large decrease in the rate of lipogenesis in vivo in the 
gland as measured with 3Hz0 ([9] ; table 6). All these 
changes in mammary gland metabolism are returned 
to normal by refeeding the starved (24 h) lactating rat 
the normal chow diet for 2 h [9,43], which indicates 
that the metabolic alterations are reversible and are 
due to short-term regulation. 
In order to identify the sites at which regulation is 
exerted it is necessary to carry out experiments in 
vitro. Much of the early work on mammary gland 
metabolism was performed with slices of the tissue, 
but recently preparations of isolated acini (secretory 
cells) have been described [44]. Acini have one 
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Table 5 
Effects of starvation (24 h) and refeeding (2 h) on utilization of blood metabolites 
by lactating mammary gland 
Metabolite Arterial concentration Arteriovenous differences 
Fed Starved Refed Fed Starved Refed 
(24 h) (2 h) (24 h) (2 h) 
Glucose 4.74 4.80 4.94 -1.43 -0.58 -2.35 
Lactate 1.75 0.98 2.66 -0.32 +0.42 -0.26 
Pyruvate 0.18 0.12 0.15 -0.03 +0.06 +0.08 
Ketone bodies 0.14 0.54 0.17 -0.005 -0.16 -0.07 
Values are taken from 143,451 and are expressed as rmol/ml whole blood 
25 August 1980 
important advantage over tissue slices in that they 
consist of a single cell type rather than a mixture of 
secretory cells and adipocytes. Their metabolism 
appears to parallel that which occurs in vivo in a vari- 
ety of situations [45]. Thus acini from starved (24 h) 
lactating rats have a decreased rate of glucose utiliza- 
tion and the proportion of glucose utilized (expressed 
as Ca units) which accumulates in the medium as 
lactate and pyruvate is 64% compared to 16% with 
acini from fed lactating rats [45]. The experiments in 
vivo and in vitro suggest hat glucose metabolism in 
starvation is inhibited at the stage of pyruvate oxida- 
tion and this is confirmed by the finding that pyruv- 
ate dehydrogenase in glands from starved rats is 
inactivated [46,47]. 
The rate of lactose synthesis in vivo as measured 
with [U-‘4C]glucose is very sensitive to food with- 
drawal and the decreased rate occurs without any 
change in the activity of galactosyltransferase [8]. 
It does not appear to be known whether the com- 
position of milk alters on short-term food withdrawal, 
but it might be expected that the fat content would 
increase and that a higher proportion of this would be 
directly derived from lipid supplied by the blood. 
To summarize, in short-term starvation glucose 
utilization by the mammary gland is decreased both 
for lipogenesis and for lactose synthesis, and of that 
glucose which is still metabolized a high proportion 
leaves the gland as lactate and pyruvate to be con- 
verted in the liver back to glucose. How the gland 
may sense the alteration in the nutritional state is dis- 
cussed in section 3.6. 
3.3. Effects of a high fat diet 
Transfer of the lactating rat from the normal labo- 
ratory diet (chow; high in carbohydrate, low in fat) 
to one high in fat might be expected to have a marked 
effect on mammary gland metabolism, because of the 
decreased availability of glucose and increased supply 
of lipid. Lactating rats fed a high fat (20%) diet for 
7-20 days show no change in the percentage of fat in 
the milk but the composition of the milk fat resem- 
bles that of the dietary fat [48,49]. In addition, the 
gain in weight of the pups is not changed on feeding 
Table 6 
Effect of diet on lipogenesis in vivo in mammary gland and liver of lactating rats 
Tissue Dietary status Ref. 
Fat-free Chow Starved Refed chow Peanut Coconut 
(24 h) (2 h) oil oil 
Mammary - 121 2.1 148 _ _ 191 
gland 70 148 - - 33 68 1491 
Liver _ 23 2.1 9 _ _ 191 
57 14 - _ 21 25 1491 
The units are gmol “Ha0 incorp. into saponified lipid . h-‘. g fresh wt tissue-r 
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the high fat diet [49]. More significant in the context 
of the present discussion is the finding that the rate 
of lipogenesis in vivo (measured with 3H20) is con- 
siderably decreased on the high fat diet (table 6; [49]) 
indicating decreased utilization of glucose by the 
gland; a similar finding has been reported in the lac- 
tating mouse [50]. Work from this laboratory with a 
cafeteria-diet (palatable supermarket foods with a 
high fat content) which induces hyperphagia, has 
shown a similar decrease in mammary gland lipogene- 
sis in vivo [51]. In this case, acini isolated from the 
glands have a depressed rate of glucose utilization and 
lipogenesis in vitro, and this can be restored to nor- 
mal by the addition of insulin [5 11. All these studies 
have involved feeding a high fat diet for several days 
and the question arises whether the metabolism of 
the gland can respond acutely to increased availability 
of lipid. We have examined the effect of an intragas- 
tric load of long or medium-chain triacylglycerols on 
lipogenesis in lactating mammary gland ([52]; table 
7). Both long and medium-chain triacylglycerols pro- 
duce a dramatic inhibition in the rate of mammary 
gland lipogenesis and this can be partially relieved 
either by an intragastric load of glucose or by adminis- 
tration of insulin [52]. This decrease of lipogenesis 
in the gland after triacylglycerol loading is an obvious 
physiological advantage in that it spares lipogenic sub- 
strates (mainly glucose) when there is increased triacyl- 
glycerol available in the blood stream. Interestingly, 
Table 7 
Acute effects of an intragastric triacylglycerol oad on 
l&genesis in vivo in mammary gland and liver of lactating 
rats 
Treatment of rats Lipogenesis 
Mammary gland Liver 
Saline 92 
Long-chain triacylglycerol 9.9 
Long-chain triacylglycerol 
+ghlcose 37 
Long-chain triacylglycerol 
+insulin 57 
Medium-chain triacylglycerol 17 
Medium-chain triacylglycerol 
+glucose 70 
Medium-chain triacylglycerol 
+insulin 67 
15.4 
8.4 
9.7 
31 
31 
29 
33 
The units are rmol ‘H,O incorporated into saponified lipid . 
h-’ . g fresh wt tissue-‘. The rate of lipogenesis was measured 
2 h after the load [52] 
acini isolated from mammary glands of rats given the 
load of triacylglycerols do not show any significant 
alteration in glucose utilization or in lipogenesis and 
this contrasts with results of experiments with cafetaria 
feeding [51] or starvation [45]. It is unlikely that the 
availability of long-chain fatty acids per se is the signal 
for decreased lipogenesis in the gland in vivo, because 
oleate has only small inhibitory effects on glucose 
utilization and lipogenesis in isolated acini [53]. 
3.4. Effects of short-term insulin deficiency 
The lactating mammary gland of the rat is consid- 
ered to be an insulin sensitive tissue [41,54], although 
as yet the precise sites where insulin may act have not 
been elucidated. Glucose oxidation and its incorpora- 
tion into lipid are decreased in mammary gland pre- 
parations (slices or cells) from lactating rats made 
insulin deficient with alloxan (2-3 days) [55,56] or 
anti-insulin serum (1 h) [55] and this impairment in 
glucose metabolism can be reversed by addition of 
insulin in vitro. But it must be emphasized that the 
effects of insulin on glucose metabolism in vitro in 
mammary gland are not as impressive as those of the 
hormone on adipose tissue. In addition, long-term 
insulin deficiency results in lower activities of key 
enzymes concerned in glucose metabolism [55] and 
this complicates the interpretation of the effects of 
insulin on the gland. However, it has been concluded 
from indirect evidence that an important action of 
insulin is to increase glucose transport into the mam- 
mary gland cell [30]. Acute insulin-deficiency (2 h) 
caused by streptozotocin administration results in a 
marked inhibition of mammary gland lipogenesis in 
vivo [9], output of pyruvate from the gland and slight 
depression of glucose uptake [45]. Surprisingly, in 
view of the conclusion that insulin promotes glucose 
transport [30], glucose utilization in acini isolated 
from streptozotocin-treated rats is not depressed, but 
its oxidation via the pentose phosphate pathway and 
its conversion to lipid are decreased [45]. In addition, 
a higher proportion of the glucose utilized accumu- 
lates in the medium as lactate and pyruvate, suggest- 
ing inhibition of pyruvate dehydrogenase. Although 
addition of insulin can partially reverse the decrease 
in the conversion of glucose to lipid it has little effect 
on the accumulation of lactate. This is analogous to 
the situation with acini from starved lactating rats 
([45], see section 3.2). Evidence for a role of insulin 
in the regulation of pyruvate dehydrogenase activity 
in mammary gland in vivo has been provided by mea- 
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surements of the activation state of the enzyme after 
short-term (3 h) streptozotocin-treatment to decrease 
circulating insulin. The percentage of active enzyme is 
decreased to <IO% without any change in the total 
activity and this inactivation is reversed by adminis- 
tration of insulin [57]. Starvation is also associated 
with marked inactivation of mammary gland pyruvate 
dehydrogenase in vivo [46,47] and this can be reversed 
by administration of glucose and insulin [47]. 
In marked contrast to the clear evidence that insu- 
lin is involved in the short-term regulation of glucose 
metabolism and lipogenesis in the lactating gland, 
there is little support for an effect of the hormone on 
lactose synthesis [8,58]. There appears to be no con- 
sistent relationship between rates of lactose synthesis 
in vivo and plasma insulin concentrations and injec- 
tion of insulin does not restore lactose synthesis 
depressed by short-term (6 h) food withdrawal [8 1. 
Furthermore, rats treated with alloxan during onset 
of lactogenesis how no decrease in the lactose con- 
tent of the gland despite low plasma insulin concen- 
trations [59]. Longer-term alloxan-diabetes does 
result in impaired pup growth [55,56] but in these 
experiments lactose synthesis was not specifically 
measured and in any case changes in enzyme concen- 
tration within the gland may have occurred. Acini 
isolated from malnourished rats do not show 
impaired lactose synthesis [58] which strongly sug- 
gests that a systemic factor is involved in the depres- 
sion of lactose synthesis in vivo. 
3.5. Effects of prolactin deficiency 
Although it is accepted that prolactin is required 
for the differentiation of the mammary gland and for 
the maintenance of lactation, comparatively little 
is known about the metabolic effects of deficiency 
of prolactin. The availability of bromocryptine, an 
inhibitor of prolactin secretion from the pituitary 
[60], has provided a valuable tool to study the meta- 
bolic roles of prolactin during lactation. 
Prolactin deficiency (24 h) does not affect the 
removal of glucose by the gland as measured by arterio- 
venous difference measurements [45], but it decreases 
the rate of lipogenesis in vivo by about 40% [61]. In 
acini isolated from prolactin-deficient lactating rats 
the utilization of glucose is slightly decreased (20%) 
as is lipogenesis and a high proportion of the glucose 
removed accumulates as lactate and pyruvate [45]. 
Bromocryptine treatment for 24 h results in the 
inactivation of pyruvate dehydrogenase in vivo [57] 
KlOO 
and the results of the experiments with acini suggest 
that the decreased activity is retained in vitro. Short- 
term prolactin deficiency (3 h) also results in inactiva- 
tion of pyruvate dehydrogenase, but to a lesser extent 
[57]. Another indication that the metabolic effects 
of prolactin deficiency are more long-term is the find- 
ing that deficiency of the hormone (3 h) does not 
prevent the stimulation of lipogenesis after refeeding 
(2 h) starved lactating rats, whereas deficiency of 
insulin does [9]. In general, the metabolic effects of 
prolactin deficiency are not so dramatic as those of 
insulin lack, but further work is required to define 
the acute action of prolactin on the gland. 
3.6. Potential ‘signals ’ to the gland 
It is clear from the preceding sections that glucose 
metabolism in the lactating gland can be radically 
altered by changes in the hormonal and/or nutritional 
state of the animal (see table 8 for a summary of the 
changes). The gland must be able to respond to the 
changes and therefore presumably it ‘recognizes’ 
alterations in the concentration of blood borne 
‘signals’. These signals may be hormones or metabo- 
lites and it is unlikely because of the complexity of 
the metabolic effects that there is a single signal. 
3.6.1. Glycerol 
The action of lipoprotein lipase on the capillary 
epithelium of the mammary gland results in the liber- 
ation of non esteritied fatty acids and glycerol from 
blood triacylglycerol [62]. A proportion of the gly- 
cerol moiety of the triacylglycerol appears in milk 
lipid but it is not known whether this enters the gland 
as free glycerol. Nevertheless, it might be expected 
that increased availability of triacylglycerol to the 
gland would result in a rise in the local concentration 
of free glycerol and thus this metabolite couId act 
as a signal to decrease glucose uptake. Glycerol at 
physiological concentrations inhibits glucose utiliza- 
tion and lipogenesis in isolated acini and this inhibi- 
tion is accompanied by a large increase in the concen- 
tration of glycerol 3-phosphate and the lactate/pyruvate 
ratio [63]. Acute elevation of the blood glycerol con- 
centration to values around 3 mM (about 30-fold 
higher than normal) does not alter the rate of lipo- 
genesis in the mammary gland (L. Agius, unpublished) 
so that it would appear that glycerol is not a signal 
in vivo. 
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Table 8 
Summary of changes in glucose metabolism of lactating mammary gland in response to alterations in diet or 
hormonal balance 
Situation In vivo In vitro Ref. 
Lipogenesis Pyruvate Glucose Lactate Lipogenesis 
dehydrogenase utilization accumulation 
activity 
Starvation (24 h) Decreased Decreased 
High-fat diet Decreased ? 
Cafeteriadiet Decreased ? 
Insulindeficiency Decreased Decreased 
Prolactindeficiency Decreased Decreased 
Triacylglycerol oad Decreased ? 
Decreased Increased 
? ? 
Decreased Slight 
increase 
Unchanged Increased 
Decreased Increased 
Unchanged Unchanged 
Decreased 
? 
Decreased 
Decreased 
Decreased 
Unchanged 
1945,471 
[48,491 
1511 
[9,45,571 
[45,57,61 I 
1521 
3.6.2. Ketone bodies 
The physiological roles of ketone bodies (acetoace- 
tate and 3-hydroxybutyrate) as substrates and signals 
for peripheral tissues is well established (reviewed 
[64]). Lactating mammary gland has high activity of 
the enzymes necessary to utilize ketone bodies [65] 
and this fact, together with the high blood flow, 
makes the gland a potential major site of ketone body 
metabolism. Ketone bodies are taken up and oxidized 
to COZ or incorporated into lipid by rat mammary 
gland both in vivo [ 10,45,66] and in vitro [63,67, 
68,691. Moreover, the presence of ketone bodies in 
the medium depresses glucose utilization by isolated 
preparations of mammary gland [66,67,69] but does 
not affect lactose synthesis (N. J. Kuhn, personal 
communication). The inhibition of glucose utilization 
is accompanied by increased concentrations of citrate 
and glucose 6-phosphate and a decreased concentra- 
tion of glycerol 3-phosphate [66,69]. The mechanism 
for the inhibition of glucose uptake is presumably 
analogous to that postulated for heart muscle [70]. 
Metabolism of ketone bodies in the mitochondria 
generates acetyl-CoA resulting in increased formation 
of citrate that is transported to the cytosol, where 
it inhibits phosphofructokinase activity. Conse- 
quently, fructose 6-phosphate concentrations rise, 
and the concomitant increase in glucose 6-phosphate 
concentration inhibits hexokinase activity, thus 
decreasing glucose uptake. In addition the increased 
concentration of acetyl-CoA may decrease the activ- 
ity of pyruvate dehydrogenase [71]. The concentra- 
tion of ketone bodies in the blood increases in starva- 
tion and therefore it has been suggested that they 
may act as a signal to depress the metabolism of glu- 
case by mammary gland when food is withdrawn 
[69]. Administration of acetoacetate to fed lactating 
rats to increase acutely the blood ketone body con- 
centrations decreases the arteriovenous difference for 
glucose across the mammary gland and causes an out- 
put of pyruvate, but not lactate [72]. These experi- 
ments provide some support for the postulate that 
ketone bodies can regulate glucose metabolism in 
mammary gland in a physiological manner. A novel 
finding is that insulin can relieve the inhibition of 
glucose utilization brought about by acetoacetate in 
vitro [66,69]. Thus in starvation the low insulin con- 
centrations [9] may potentiate the inhibition of glu- 
cose utilization and lipogenesis by ketone bodies. It 
should be mentioned that the ketone body concentra- 
tions in the blood of 24 h starved lactating rats are 
lower than those found in starved virgin rats [lo]; 
this may be due to increased ketone body removal by 
the gland or to decreased production by the liver [ 191. 
3.6.3. Insulin 
It is clear from the preceding discussion (in partic- 
ular section 3.4) that insulin plays a key role in the 
short-term regulation of mammary gland metabolism. 
It is therefore somewhat surprising to find that the 
plasma insulin concentration is lower during lacta- 
tion than in virgin or non-lactating rats [5,9]. The 
blood glucose concentration is also about 1.5 mmol/l 
lower at peak lactation and recent experiments have 
shown that the plasma insulin is appropriate to the 
existing level of glycaemia (P. FerrC and J. R. Girard, 
personal communication). It may be that the high 
rate of glucose utilization by the gland is the reason 
KlOl 
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for the lower blood glucose during lactation, and this 
in turn might be responsible for the relative hypoin- 
sulinaemia. As mammary gland is an insulin-sensitive 
tissue [41,54] how can one reconcile this apparent 
anomaly of a low plasma insulin being correlated 
with a high rate of glucose metabolism in the mam- 
mary gland? One possibility is that the lactating gland 
acts as a ‘sink’ for insulin, in that the tissue is likely 
to contain a large number of insulin receptors and the 
hormone is delivered to the gland at a fast rate due to 
the high blood flow..Recent experiments with the- 
lectomized glands (removal of teats) have indicated 
the importance of the rate of delivery of hormones, 
rather than the blood concentrations, in the regula- 
tion of tissue receptor levels for prolactin and oestro- 
gen [73]. Further support for the postulate that the 
lactating gland is a major site of insulin (and glucose) 
uptake is the finding that on removal of the pups (24 
h) when the blood flow to the gland is halved [74] 
the blood glucose increases by 0.6 mmol/l and the 
plasma insulin rises 3-fold [61]. The decrease in 
plasma insulin on starvation and the rapid increase on 
refeeding [IO] are in agreement with the postulated 
role of insulin as a signal of carbohydrate availability 
to the gland. It is not known whether mammary 
gland blood flow changes in these situations. 
Assuming that the rate of insulin delivery is an 
important signal for the regulation of metabolism in 
the gland the question is the site(s) at which it may 
act. Apart from the postulated effect of insulin on 
membrane transport of glucose [30], an important 
site action of the hormone appears to be on pyruvate 
dehydrogenase activity. Attempts to study the mech- 
anism whereby insulin may alter the activation state 
of this enzyme have been frustrated by the inability 
to demonstrate an effect of the hormone on the activ. 
ity in vitro [36,45]. Indirect evidence suggests that 
insulin may act via modulation of the activity of the 
pyruvate dehydrogenase kinase and pyruvate dehy- 
drogenase phosphatase responsible for the intercon- 
version of the active and inactive forms of the pyr- 
uvate dehydrogenase complex [75-771. However, 
pyruvate dehydrogenase may not be the only intra- 
cellular site at which insulin acts. Insulin causes only 
a slight increase in lipogenesis in acini prepared from 
glands of starved lactating rats [45], but if pyruvate 
dehydrogenase is activated by inclusion of dichloro- 
acetate in the medium [78] insulin causes a $onsider- 
ably greater stimulation of lipogenesis (M. R. Munday 
and D. H. Williamson, unpublished). This suggests 
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that insulin can activate a step which is after pyruvate 
dehydrogenase in the pathway of lipogenesis. A 
potential candidate is acetyl-CoA carboxylase, which 
is known to be a regulatory protein and to undergo 
phosphorylation and inactivation in response to 
adrenaline in adipose tissue [78,79,8 1 ] and to glucagon 
in liver cells [80]. Purified acetyl-CoA carboxylase 
from rabbit mammary gland can be phosphorylated 
by both cyclic AMP-dependent and -independent pro- 
tein kinases [82] though as yet no hormone has been 
shown to inactivate the mammary gland enzyme or 
even inhibit lipogenesis in an in vitro preparation of 
the gland. How insulin might regulate the activity of 
acetyl-CoA carboxylase in mammary gland is still an 
open question. 
4. Integration of mammary gland metabolism with 
that of other tissues 
If, as seems likely, the availability of insulin is a 
key factor in regulating the metabolism of the lactat- 
ing mammary gland of the rat, this raises a problem 
in that insulin also controls anabolic processes in adi- 
pose tissue and liver of non-lactating rats. In lactation 
there must therefore be mechanisms whereby the 
influence of insulin on tissues other than mammary 
gland is depressed. This could be achieved either by: 
(i) ‘Directing’ the hormone to the gland (as postu- 
lated in section 3.6.3.) and presenting the other 
tissues with a lower plasma concentration of 
insulin; or 
(ii) Decreasing the number of insulin receptors; or 
(iii) Increasing the concentration of a hormone which 
acts antagonistically to insulin except in mam- 
mary tissue. 
These changes might in turn bring about alterations in 
the concentrations or activities of key enzymes, e.g. 
[ 121. The number of insulin receptors is not altered 
in hepatocytes [83] or adipocytes [S] during lacta- 
tion, whereas the receptor numbers are increased in 
these tissues during pregnancy. Prolactin would seem 
an excellent candidate to act as antagonist to insulin 
in liver and adipose tissue because its secretion is 
directly coupled to the suckling reflex [84] and 
therefore its plasma concentration signals the lacta- 
tional drive. This section is concerned with integra- 
tion of lipid metabolism between mammary gland, 
liver and adipose tissue and the possible role of pro- 
lactin in this process. 
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4.1. Lipoprotein lipase activity and triacylglycerol 
uptake 
The key mechanism for regulating the inter-organ 
flux of triacylglycerol during lactation is the recipro* 
cal changes in the activity of lipoprotein lipase in 
adipose tissue and mammary gland [6,13]. The activ- 
ity of the enzyme decreases in adipose tissue just 
before parturition and remains low throughout lacta- 
tion, whereas the activity in mammary gland rapidly 
increases at the end of pregnancy to reach high levels 
at peak lactation; the net result of these changes is 
that triacylglycerol available in the circulation is 
‘directed’ to the mammary gland rather than to adi- 
pose tissue [4]. There is good evidence that the high 
plasma concentrations of prolactin during lactation 
are responsible for maintaining this different pattern 
of lipoprotein lipase activity between the two tissues 
[85]. Thus removal of the pups [6,86] or hypophy- 
sectomy of the lactating mother [85], both of which 
lower the plasma prolactin, result in a rapid increase 
in lipoprotein lipase activity in adipose tissue and a 
decrease in the mammary gland. The signals that trig- 
ger the changes in lipoprotein lipase activity around 
parturition are more complex [87]. It appears that 
prostaglandin Flcu initiates the alterations in lipopro- 
tein lipase activity, whereas progesterone acts as a 
repressor [87]; the latter may also suppress lactogene- 
sis [88]. 
4.2. Lipogenesis 
The primary substrate for the synthesis de novo of 
lipid is glucose (or glycogen) and in order to conserve 
carbohydrate for the mammary gland the rate of lipo- 
genesis must be decreased in adipose tissue and, to a 
lesser extent, in liver. There is ample evidence in 
vitro [5,1 l] and in vivo [9,61] that the rate of lipo- 
genesis in adipose tissue is decreased uring lactation. 
In liver the rate of lipogenesis in vitro is higher than 
in the non-lactating rat [ 19,891 but the rate in vivo is 
not increased, suggesting that a systemic factor may 
depress hepatic lipogenesis in vivo. If pups are re- 
moved from the mother for 24 h lipogenesis increases 
4-fold in maternal adipose tissue and doubles in liver 
and these increases can be prevented by administra- 
tion of prolactin [61]. Treatment of lactating rats in 
the presence of the pups with bromocryptine (24 h) 
increases lipogenesis in both adipose tissue and liver 
and again this does not occur of prolactin is adminis- 
tered simultaneously [61]. Removal of pups for 48 h 
increases the number of insulin receptors on para- 
metrial adipose tissue and the rate of fatty acid syn- 
thesis in vitro [90]; these changes cannot be reversed 
by prolactin which indicates that the hormone’s 
effects may be transient. These experiments suggest 
that alteration of the plasma prolactin concentration 
causes a reciprocal change in the rate of lipogenesis 
in both liver and adipose tissue. The advantage of 
this regulatory role for prolactin is that an elevation 
of the hormone in response to the suckling stimulus 
would depress lipogenesis in adipose tissue and liver 
so that glucose and lactate, the two main lipogenic 
precursors [44], are made available for the lactating 
gland. The fall in prolactin concentration on weaning 
allows replenishment of the depleted lipid stores in 
adipose tissue. It appears that the changes in lipopro- 
tein lipase activity and lipogenesis in adipose tissue 
during lactation are synchronized [S,90] and that 
prolactin is the likely signal. Whether prolactin is 
responsible for the changes in hepatic lipid metabo- 
lism [18,19,61] is less certain. Rat liver does have 
prolactin receptors [91] although their role is not 
known. In addition, prolactin has been shown to 
depress hepatic lipogenesis in a teleost [92]. One 
problem in ascribing a primary role to prolactin in 
the regulation of lipogenesis is that, at least in the 
short-term, changes in plasma prolactin concentration 
are accompanied by reciprocal changes in plasma 
insulin [61]. It has been suggested that these effects 
of prolactin on lipogenesis require a functioning 
mammary gland [90] and this would explain why 
long-term hyperprolactinaemia in non-lactating rats 
does not bring about the same changes (L. Agius and 
D. H. Williamson, unpublished). 
5. The future 
The work reviewed here indicates that the metabo- 
lism of the tissues of the lactating rat is closely inte- 
grated so that the substrate and energy demands of 
lactation are met. Some progress has been made in 
our understanding of how the integration is achieved 
but much remains to be discovered, particularly in 
the areas of amino acid metabolism, regulation of 
enzyme turnover, and the role of the gut hormones. 
Apart from the acquisition of new knowledge further 
advances in this field may one day allow us to inter- 
vene experimentally to obtain the alterations in tissue 
metabolism and inter-organ substrate fluxes similar to 
those that the rat experiences during successive preg- 
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nancies and lactation. The eventual prize might be a 
novel means of controlling obesity. 
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